Promising AD treatments remain in pipeline: amyloid fibril antiaggregation therapy and neurotrophic agents are still under consideration.(GERIATRIC ... An article from: Clinical Psychiatry News
Book Details
Author(s)Bruce Jancin
PublisherInternational Medical News Group
ISBN / ASINB005EVIIVI
ISBN-13978B005EVIIV7
AvailabilityAvailable for download now
MarketplaceUnited States 🇺🇸
Description
This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on June 1, 2011. The length of the article is 865 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details
Title: Promising AD treatments remain in pipeline: amyloid fibril antiaggregation therapy and neurotrophic agents are still under consideration.(GERIATRIC PSYCHIATRY)
Author: Bruce Jancin
Publication:Clinical Psychiatry News (Magazine/Journal)
Date: June 1, 2011
Publisher: International Medical News Group
Volume: 39 Issue: 6 Page: 30(1)
Distributed by Gale, a part of Cengage Learning
Citation Details
Title: Promising AD treatments remain in pipeline: amyloid fibril antiaggregation therapy and neurotrophic agents are still under consideration.(GERIATRIC PSYCHIATRY)
Author: Bruce Jancin
Publication:Clinical Psychiatry News (Magazine/Journal)
Date: June 1, 2011
Publisher: International Medical News Group
Volume: 39 Issue: 6 Page: 30(1)
Distributed by Gale, a part of Cengage Learning
More Books by Bruce Jancin
